Envestnet Asset Management Inc. Takes $257,000 Position in CoreCivic, Inc. (NYSE:CXW)

Envestnet Asset Management Inc. acquired a new stake in CoreCivic, Inc. (NYSE:CXW - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 11,825 shares of the real estate investment trust's stock, valued at approximately $257,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Barclays PLC raised its holdings in shares of CoreCivic by 312.4% in the third quarter. Barclays PLC now owns 184,332 shares of the real estate investment trust's stock worth $2,331,000 after buying an additional 139,631 shares during the last quarter. Tidal Investments LLC acquired a new stake in CoreCivic in the 3rd quarter valued at $139,000. GAMMA Investing LLC grew its holdings in shares of CoreCivic by 25.5% in the fourth quarter. GAMMA Investing LLC now owns 4,686 shares of the real estate investment trust's stock valued at $102,000 after purchasing an additional 953 shares during the period. Nisa Investment Advisors LLC increased its holdings in shares of CoreCivic by 13,071.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 253,147 shares of the real estate investment trust's stock worth $5,503,000 after buying an additional 251,225 shares during the last quarter. Finally, Exchange Traded Concepts LLC raised its position in CoreCivic by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 57,312 shares of the real estate investment trust's stock valued at $1,246,000 after purchasing an additional 1,450 shares during the period. Institutional investors own 85.13% of the company's stock.

CoreCivic Stock Performance

Shares of CXW stock opened at $22.67 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.51 and a current ratio of 1.57. The stock has a market cap of $2.48 billion, a PE ratio of 37.16 and a beta of 0.79. CoreCivic, Inc. has a 1 year low of $10.74 and a 1 year high of $24.99. The stock has a fifty day moving average price of $20.74 and a 200 day moving average price of $20.33.

CoreCivic (NYSE:CXW - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.10. The company had revenue of $488.60 million during the quarter, compared to analysts' expectations of $478.49 million. CoreCivic had a return on equity of 5.97% and a net margin of 3.51%. The business's revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 earnings per share. Sell-side analysts forecast that CoreCivic, Inc. will post 1.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CXW has been the topic of several research analyst reports. Wedbush reiterated an "outperform" rating and issued a $30.00 price objective on shares of CoreCivic in a report on Tuesday, February 11th. StockNews.com upgraded shares of CoreCivic from a "hold" rating to a "buy" rating in a research note on Wednesday. Finally, Noble Financial upgraded shares of CoreCivic from a "market perform" rating to an "outperform" rating in a research note on Wednesday, February 12th.

About CoreCivic

CoreCivic, Inc owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides a range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.